Catherine M. Kelly

Researcher Next ID · RN-040750

Researcher · Biochemistry, Genetics and Molecular Biology

Dublin, Ireland

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Advanced Breast Cancer Therapies

Breast Cancer Treatment Studies

HER2/EGFR in Cancer Research

Cancer Immunotherapy and Biomarkers

Cancer Treatment and Pharmacology

Spatial predictors of immunotherapy response in triple-negative breast cancer
Nature · 2023 · https://doi.org/10.1038/s41586-023-06498-3
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study
Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.02.004
Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2016.71.3495
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx651
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
BMJ · 2010 · https://doi.org/10.1136/bmj.c693

No projects listed.